Skip to main content
Clinical Trials/CTRI/2024/02/062647
CTRI/2024/02/062647Not yet recruitingPhase 4

Efficacy of continuous glucose monitoring for glycaemic control over standard treatment and monitoring in individuals with uncontrolled type 2 diabetes in Khordha district: A randomized control trial. - NI

Dr.Priyamadhabha Behera0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Individuals with type 2 diabetes on 3 or more oral antidiabetic agents with or without insulin HbA1C more than 7%.

Exclusion Criteria

  • Individuals with type 1 diabetes
  • Gestational diabetes mellitus
  • Individuals with diabetic complications (acute or chronic)
  • Individuals with a history of bleeding disorder
  • Individuals with a recent history of steroid use

Investigators

Sponsor
Dr.Priyamadhabha Behera

Similar Trials

Role of continuous glucose monitoring... | Clinical Trial